Clinical trials
Completed Ankle Injuries trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
194 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 7 |
| 2009 | 9 |
| 2010 | 8 |
| 2011 | 4 |
| 2012 | 4 |
| 2013 | 7 |
| 2014 | 9 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 8 |
| 2018 | 14 |
| 2019 | 16 |
| 2020 | 11 |
| 2021 | 13 |
| 2022 | 20 |
| 2023 | 21 |
| 2024 | 16 |
| 2025 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 194 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis | 5 |
| Riphah International University | 5 |
| Acibadem University | 3 |
| Bahçeşehir University | 3 |
| Creighton University | 3 |
| Hisamitsu Pharmaceutical Co., Inc. | 3 |
| Istituto Ortopedico Rizzoli | 3 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 3 |
| Paragon 28 | 3 |
| University of Lahore | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ankle Injuries | 194 |
| Disease | 13 |
| Sprains and Strains | 13 |
| Foot Injuries | 12 |
| Joint Instability | 11 |
| Knee Injuries | 11 |
| Pain | 11 |
| Ankle Fractures | 9 |
| Wounds and Injuries | 9 |
| Athletic Injuries | 6 |
Trials
Showing 1 to 25 of 194. Each trial links to its page on Pharma Observatory.
94 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.